GE HealthCare Technologies Inc. 8-K

What Happened
GE HealthCare Technologies Inc. announced the results of its May 7, 2026 annual meeting of stockholders in an 8-K filed May 11, 2026. Stockholders elected eight directors to one-year terms, approved the advisory "say-on-pay" vote for named executive compensation, and ratified Deloitte & Touche LLP as independent auditor for fiscal 2026. The Board also appointed Rodney F. Hochman as independent lead director and Anne T. Madden as chairperson of the Nominating and Governance Committee, both effective May 7, 2026.

Key Details

• Directors elected (sample vote totals): Peter J. Arduini — 363,637,737 For; H. Lawrence Culp, Jr. — 351,620,004 For (12,409,707 Against); Kevin A. Lobo — 332,339,981 For (32,058,693 Against). Each director had 34,599,625 broker non‑votes.
• Advisory vote on executive compensation: 351,099,781 For; 12,973,200 Against; 795,207 Abstentions; 34,599,625 broker non‑votes.
• Auditor ratification: Deloitte & Touche LLP ratified as independent auditor for 2026 — 398,257,878 For; 769,608 Against; 440,327 Abstentions.
• Governance appointments: Rodney F. Hochman named independent lead director; Anne T. Madden named chair of the Nominating and Governance Committee (effective May 7, 2026).

Why It Matters
The filing confirms shareholder approval of the board slate, executive compensation (advisory), and the company’s auditor—key governance outcomes investors watch for continuity and oversight. The appointment of an independent lead director and a new Nominating & Governance chair signals board-level leadership assignments that may influence oversight and governance practices going forward.